About Careers MedBlog Contact us

Cardiovascular Effects of Two Drugs for Diabetic Patients Show Neutral Results

by Julia Samuel on April 16, 2015 at 4:38 PM
Font : A-A+

Cardiovascular Effects of Two Drugs for Diabetic Patients Show Neutral Results

The Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee discussed on the approval and recommendations for two diabetic drugs.

The committee voted against any harsh measures, recommending only that information from two neutral clinical trials with the drugs be added to the drugs' labels and rejected withdrawal or new restrictions.


The trials on two DPP-4 inhibitors, saxagliptin and alogliptin, concluded that the results show no evidence of either cardiovascular benefit or harm. DPP-4 inhibitors reduce glucagon and blood glucose levels and increases incretin levels, which increase insulin secretion and decreases gastric emptying.

SAVOR-TIMI 53 studied saxagliptin (Onglyza, AstraZeneca) and EXAMINE studied alogliptin (Nesina, Takeda Pharmaceuticals). FDA reviewers raised concerns about a possible increase in death with the drugs. Panel members were unable to find any consistency in the data and expressed concerns over a consistent signal for heart failure complications.

Panel members called on the FDA to get companies to study the heart failure question more closely. Without any evidence of cardiovascular benefit, the panelist said, "the diabetes community needs to demonstrate that lowering HbA1c is beneficial."

Source: Medindia


Recommended Reading

Latest Drug News

 Understanding Why Aspirin is a Magic Drug for Inflammation
New discoveries about aspirin's interplay between messenger molecules that are crucial in the inflammatory proves again that it is a powerful anti-inflammatory drug.
Is Fomepizole the Key to Overcoming Antibiotic-Resistant Pneumonia?
The new drug target sheds insights into strategies to fight drug-resistant S. pneumoniae, stated research.
 Combination Therapy Benefits Septic Shock Patients
The effectiveness of adding fludrocortisone to hydrocortisone vs hydrocortisone alone among patients with septic shock was analyzed using target trial emulation.
Are Painkillers Safe for Back Pain?
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Cardiovascular Effects of Two Drugs for Diabetic Patients Show Neutral Results Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests